The inhibition of GSK-3β induces β-catenin accumulation and plays a vital role in chemical agent-induced growth inhibition and apoptosis in lung cancer cells, such as tivantinib and dihydroartemisinin [40,41]. This evidence concerns the gene GSK3B and lung carcinoma.